Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes
- 26 April 2010
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 95 (8), 1433-1434
- https://doi.org/10.3324/haematol.2010.024992
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Myelodysplasia paranoia: Iron as the new radonLeukemia Research, 2009
- Iron: The fifth horseman of the apocalypse?American Journal of Hematology, 2009
- Intracellular labile ironThe International Journal of Biochemistry & Cell Biology, 2008
- Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndromeEuropean Journal of Haematology, 2007
- Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidantsBritish Journal of Haematology, 2005
- LPI-labile plasma iron in iron overloadBest Practice & Research Clinical Haematology, 2005
- Management of anemia associated with myelodysplastic syndromeSeminars in Hematology, 2005
- Myelodysplastic SyndromesHematology-American Society Hematology Education Program, 2002
- Redox state of glutathione in human plasmaFree Radical Biology & Medicine, 2000
- Pathophysiology of Iron OverloadaAnnals of the New York Academy of Sciences, 1998